Usefulness of R.E.N.A.L. nephrometry scoring system for predicting outcomes and complications of percutaneous ablation of 751 renal tumors

Grant D. Schmit, R. Houston Thompson, Anil N. Kurup, Adam J. Weisbrod, Stephen A. Boorjian, Rickey E. Carter, Jennifer R. Geske, Matthew R Callstrom, Thomas D. Atwell

Research output: Contribution to journalArticle

89 Citations (Scopus)

Abstract

Purpose: We applied the R.E.N.A.L. (radius, exophytic/endophytic, nearness to collecting system or sinus, anterior/posterior and location relative to polar lines) nephrometry scoring system to renal tumors treated with percutaneous ablation to determine whether this score is associated with oncological outcomes and complications. Materials and Methods: A total of 751 renal tumors were treated at 679 percutaneous ablation sessions in 627 patients at our institution between 2000 and 2012. Of these renal masses 430 (57%) were treated with cryoablation and the remaining 321 were treated with radio frequency ablation. R.E.N.A.L. tumor scores were analyzed to determine the association of the score with ablation treatment outcomes and complications according to Clavien criteria. Results: The mean ± SD R.E.N.A.L. nephrometry score of all ablated tumors was 6.7 ± 1.9. Those treated with cryoablation had higher scores than those treated with radio frequency ablation (mean 7.2 ± 1.9 vs 6.1 ± 1.8, p <0.001). We identified a total of 28 local treatment failures (3.7%) in the 751 tumors during a mean computerized tomography/magnetic resonance imaging followup of 27.9 ± 27.8 months. There was a significant association between R.E.N.A.L. nephrometry score and local treatment failure. Mean nephrometry score was 7.6 ± 2.2 vs 6.7 ± 1.9 for tumors with vs without local treatment failure (p <0.001). Of the 679 ablation treatments 38 (5.6%) major (grade 3 or greater) patient complications occurred. There was a significant association between R.E.N.A.L. nephrometry score and major complications. Patients with vs without a major complication had a mean nephrometry score of 8.1 ± 2.0 vs 6.8 ± 1.9 (p <0.001). Conclusions: The R.E.N.A.L. nephrometry scoring system predicts treatment efficacy and complications following percutaneous renal ablation.

Original languageEnglish (US)
Pages (from-to)30-35
Number of pages6
JournalJournal of Urology
Volume189
Issue number1
DOIs
StatePublished - Jan 2013

Fingerprint

Kidney
Treatment Failure
Neoplasms
Cryosurgery
Radio
Tomography
Magnetic Resonance Imaging
Therapeutics

Keywords

  • carcinoma renal cell
  • catheter ablation
  • cryosurgery
  • forecasting
  • kidney

ASJC Scopus subject areas

  • Urology

Cite this

Usefulness of R.E.N.A.L. nephrometry scoring system for predicting outcomes and complications of percutaneous ablation of 751 renal tumors. / Schmit, Grant D.; Thompson, R. Houston; Kurup, Anil N.; Weisbrod, Adam J.; Boorjian, Stephen A.; Carter, Rickey E.; Geske, Jennifer R.; Callstrom, Matthew R; Atwell, Thomas D.

In: Journal of Urology, Vol. 189, No. 1, 01.2013, p. 30-35.

Research output: Contribution to journalArticle

Schmit, Grant D. ; Thompson, R. Houston ; Kurup, Anil N. ; Weisbrod, Adam J. ; Boorjian, Stephen A. ; Carter, Rickey E. ; Geske, Jennifer R. ; Callstrom, Matthew R ; Atwell, Thomas D. / Usefulness of R.E.N.A.L. nephrometry scoring system for predicting outcomes and complications of percutaneous ablation of 751 renal tumors. In: Journal of Urology. 2013 ; Vol. 189, No. 1. pp. 30-35.
@article{d3c9a71d9f9b4749a10a22ab74c6d651,
title = "Usefulness of R.E.N.A.L. nephrometry scoring system for predicting outcomes and complications of percutaneous ablation of 751 renal tumors",
abstract = "Purpose: We applied the R.E.N.A.L. (radius, exophytic/endophytic, nearness to collecting system or sinus, anterior/posterior and location relative to polar lines) nephrometry scoring system to renal tumors treated with percutaneous ablation to determine whether this score is associated with oncological outcomes and complications. Materials and Methods: A total of 751 renal tumors were treated at 679 percutaneous ablation sessions in 627 patients at our institution between 2000 and 2012. Of these renal masses 430 (57{\%}) were treated with cryoablation and the remaining 321 were treated with radio frequency ablation. R.E.N.A.L. tumor scores were analyzed to determine the association of the score with ablation treatment outcomes and complications according to Clavien criteria. Results: The mean ± SD R.E.N.A.L. nephrometry score of all ablated tumors was 6.7 ± 1.9. Those treated with cryoablation had higher scores than those treated with radio frequency ablation (mean 7.2 ± 1.9 vs 6.1 ± 1.8, p <0.001). We identified a total of 28 local treatment failures (3.7{\%}) in the 751 tumors during a mean computerized tomography/magnetic resonance imaging followup of 27.9 ± 27.8 months. There was a significant association between R.E.N.A.L. nephrometry score and local treatment failure. Mean nephrometry score was 7.6 ± 2.2 vs 6.7 ± 1.9 for tumors with vs without local treatment failure (p <0.001). Of the 679 ablation treatments 38 (5.6{\%}) major (grade 3 or greater) patient complications occurred. There was a significant association between R.E.N.A.L. nephrometry score and major complications. Patients with vs without a major complication had a mean nephrometry score of 8.1 ± 2.0 vs 6.8 ± 1.9 (p <0.001). Conclusions: The R.E.N.A.L. nephrometry scoring system predicts treatment efficacy and complications following percutaneous renal ablation.",
keywords = "carcinoma renal cell, catheter ablation, cryosurgery, forecasting, kidney",
author = "Schmit, {Grant D.} and Thompson, {R. Houston} and Kurup, {Anil N.} and Weisbrod, {Adam J.} and Boorjian, {Stephen A.} and Carter, {Rickey E.} and Geske, {Jennifer R.} and Callstrom, {Matthew R} and Atwell, {Thomas D.}",
year = "2013",
month = "1",
doi = "10.1016/j.juro.2012.08.180",
language = "English (US)",
volume = "189",
pages = "30--35",
journal = "Journal of Urology",
issn = "0022-5347",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - Usefulness of R.E.N.A.L. nephrometry scoring system for predicting outcomes and complications of percutaneous ablation of 751 renal tumors

AU - Schmit, Grant D.

AU - Thompson, R. Houston

AU - Kurup, Anil N.

AU - Weisbrod, Adam J.

AU - Boorjian, Stephen A.

AU - Carter, Rickey E.

AU - Geske, Jennifer R.

AU - Callstrom, Matthew R

AU - Atwell, Thomas D.

PY - 2013/1

Y1 - 2013/1

N2 - Purpose: We applied the R.E.N.A.L. (radius, exophytic/endophytic, nearness to collecting system or sinus, anterior/posterior and location relative to polar lines) nephrometry scoring system to renal tumors treated with percutaneous ablation to determine whether this score is associated with oncological outcomes and complications. Materials and Methods: A total of 751 renal tumors were treated at 679 percutaneous ablation sessions in 627 patients at our institution between 2000 and 2012. Of these renal masses 430 (57%) were treated with cryoablation and the remaining 321 were treated with radio frequency ablation. R.E.N.A.L. tumor scores were analyzed to determine the association of the score with ablation treatment outcomes and complications according to Clavien criteria. Results: The mean ± SD R.E.N.A.L. nephrometry score of all ablated tumors was 6.7 ± 1.9. Those treated with cryoablation had higher scores than those treated with radio frequency ablation (mean 7.2 ± 1.9 vs 6.1 ± 1.8, p <0.001). We identified a total of 28 local treatment failures (3.7%) in the 751 tumors during a mean computerized tomography/magnetic resonance imaging followup of 27.9 ± 27.8 months. There was a significant association between R.E.N.A.L. nephrometry score and local treatment failure. Mean nephrometry score was 7.6 ± 2.2 vs 6.7 ± 1.9 for tumors with vs without local treatment failure (p <0.001). Of the 679 ablation treatments 38 (5.6%) major (grade 3 or greater) patient complications occurred. There was a significant association between R.E.N.A.L. nephrometry score and major complications. Patients with vs without a major complication had a mean nephrometry score of 8.1 ± 2.0 vs 6.8 ± 1.9 (p <0.001). Conclusions: The R.E.N.A.L. nephrometry scoring system predicts treatment efficacy and complications following percutaneous renal ablation.

AB - Purpose: We applied the R.E.N.A.L. (radius, exophytic/endophytic, nearness to collecting system or sinus, anterior/posterior and location relative to polar lines) nephrometry scoring system to renal tumors treated with percutaneous ablation to determine whether this score is associated with oncological outcomes and complications. Materials and Methods: A total of 751 renal tumors were treated at 679 percutaneous ablation sessions in 627 patients at our institution between 2000 and 2012. Of these renal masses 430 (57%) were treated with cryoablation and the remaining 321 were treated with radio frequency ablation. R.E.N.A.L. tumor scores were analyzed to determine the association of the score with ablation treatment outcomes and complications according to Clavien criteria. Results: The mean ± SD R.E.N.A.L. nephrometry score of all ablated tumors was 6.7 ± 1.9. Those treated with cryoablation had higher scores than those treated with radio frequency ablation (mean 7.2 ± 1.9 vs 6.1 ± 1.8, p <0.001). We identified a total of 28 local treatment failures (3.7%) in the 751 tumors during a mean computerized tomography/magnetic resonance imaging followup of 27.9 ± 27.8 months. There was a significant association between R.E.N.A.L. nephrometry score and local treatment failure. Mean nephrometry score was 7.6 ± 2.2 vs 6.7 ± 1.9 for tumors with vs without local treatment failure (p <0.001). Of the 679 ablation treatments 38 (5.6%) major (grade 3 or greater) patient complications occurred. There was a significant association between R.E.N.A.L. nephrometry score and major complications. Patients with vs without a major complication had a mean nephrometry score of 8.1 ± 2.0 vs 6.8 ± 1.9 (p <0.001). Conclusions: The R.E.N.A.L. nephrometry scoring system predicts treatment efficacy and complications following percutaneous renal ablation.

KW - carcinoma renal cell

KW - catheter ablation

KW - cryosurgery

KW - forecasting

KW - kidney

UR - http://www.scopus.com/inward/record.url?scp=84870895132&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84870895132&partnerID=8YFLogxK

U2 - 10.1016/j.juro.2012.08.180

DO - 10.1016/j.juro.2012.08.180

M3 - Article

C2 - 23164375

AN - SCOPUS:84870895132

VL - 189

SP - 30

EP - 35

JO - Journal of Urology

JF - Journal of Urology

SN - 0022-5347

IS - 1

ER -